Kronos Bio Inc. (KRON)
0.96
-0.02 (-2.04%)
At close: Mar 03, 2025, 11:49 AM
Kronos Bio Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -112.67M | -133.2M | -151.08M | -88.44M | -16.12M | -6.72M |
| Depreciation & Amortization | 2.14M | 2.27M | 1.98M | 839K | 356K | 91K |
| Stock-Based Compensation | 24.98M | 31.14M | 26.21M | 3.75M | 113K | 30K |
| Other Working Capital | 10.02M | 2.15M | 1.57M | 3.65M | -440K | 118K |
| Other Non-Cash Items | 1.1M | 2.69M | 2.59M | 39.15M | 294K | 69K |
| Deferred Income Tax | n/a | n/a | 4M | 326K | -4K | n/a |
| Change in Working Capital | 5.88M | 6.18M | -1.62M | 6.46M | 276K | 90K |
| Operating Cash Flow | -78.58M | -90.93M | -117.92M | -37.91M | -15.08M | -6.44M |
| Capital Expenditures | -679K | -577K | -4.26M | -9.57M | -2.95M | -1.07M |
| Acquisitions | n/a | 31.64M | -67.98M | 150.67M | n/a | n/a |
| Purchase of Investments | -212.96M | -367.12M | -177.73M | -229.33M | -64.63M | n/a |
| Sales Maturities Of Investments | 280M | 335.48M | 245.72M | 78.66M | n/a | n/a |
| Other Investing Acitivies | -1 | -31.64M | 67.98M | -150.67M | -64.63M | n/a |
| Investing Cash Flow | 66.37M | -32.22M | 63.72M | -160.24M | -67.58M | -1.07M |
| Debt Repayment | n/a | n/a | -5K | 151.24M | -30K | -72K |
| Common Stock Repurchased | 538K | 380K | 1.34M | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 567K | 851K | 4.46M | 264.37M | 105.04M | 16.29M |
| Financial Cash Flow | 567K | 851K | 4.46M | 415.61M | 105.01M | 16.22M |
| Net Cash Flow | -11.65M | -122.3M | -49.74M | 217.47M | 22.34M | 8.7M |
| Free Cash Flow | -79.26M | -91.5M | -122.18M | -47.48M | -18.03M | -7.52M |